News
GAITHERSBURG, Md., June 22, 2020 -- Arcellx, a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients.
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) -- Arcellx, a clinical-stage biopharmaceutical company developing novel, adaptive and controll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback